Xiamen Amoytop Biotech Co., Ltd.

SHSE:688278 Voorraadrapport

Marktkapitalisatie: CN¥29.1b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Xiamen Amoytop Biotech Toekomstige groei

Future criteriumcontroles 6/6

Xiamen Amoytop Biotech is forecast to grow earnings and revenue by 30.8% and 28% per annum respectively. EPS is expected to grow by 30.8% per annum. Return on equity is forecast to be 30.5% in 3 years.

Belangrijke informatie

30.8%

Groei van de winst

30.8%

Groei van de winst per aandeel

Biotechs winstgroei38.5%
Inkomstengroei28.0%
Toekomstig rendement op eigen vermogen30.5%
Dekking van analisten

Good

Laatst bijgewerkt18 Sep 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Sep 19
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Sep 19
Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%

Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Jun 12
Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?

Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 04
Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Mar 25
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk

Winst- en omzetgroeiprognoses

SHSE:688278 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20264,7941,3971,1221,3007
12/31/20253,6761,0428369907
12/31/20242,8027605257865
6/30/20242,387658267534N/A
3/31/20242,226600241569N/A
12/31/20232,100555224512N/A
9/30/20231,843456275519N/A
6/30/20231,716356-11262N/A
3/31/20231,60131497302N/A
12/31/20221,527287144363N/A
9/30/20221,46625447287N/A
6/30/20221,37824371286N/A
3/31/20221,26220450262N/A
12/31/20211,13218144235N/A
9/30/20211,04316845208N/A
6/30/20219041423164N/A
3/31/20218221280135N/A
12/31/2020794117-2693N/A
9/30/20207629825117N/A
6/30/20207719560121N/A
3/31/20207718663118N/A
12/31/20197306478123N/A
9/30/20196655861100N/A
12/31/2018448167589N/A
12/31/20173235N/A-11N/A
12/31/201628029N/A42N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 688278's forecast earnings growth (30.8% per year) is above the savings rate (2.9%).

Winst versus markt: 688278's earnings (30.8% per year) are forecast to grow faster than the CN market (23.2% per year).

Hoge groeiwinsten: 688278's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 688278's revenue (28% per year) is forecast to grow faster than the CN market (13.2% per year).

Hoge groei-inkomsten: 688278's revenue (28% per year) is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 688278's Return on Equity is forecast to be high in 3 years time (30.5%)

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y